Solasto Corporation (JPX: 6197.T) Stock Competitors & Peer Comparison
See 6197.T's competitors and their performance on the JPX and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for 6197.T and its JPX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 6197.T | ¥1,111.00 | +0.00% | 100.6B | 27.22 | ¥40.82 | +1.98% |
| 6099.T | ¥786.00 | +1.81% | 46.7B | 16.00 | ¥48.24 | +1.94% |
| 6062.T | ¥1,373.00 | +2.77% | 44.2B | 11.90 | ¥113.67 | +3.18% |
| 7071.T | ¥373.00 | +0.81% | 35.3B | 12.26 | ¥29.37 | +1.11% |
| 2372.T | ¥2,790.00 | +0.00% | 33.8B | 131.60 | ¥21.20 | N/A |
| 2374.T | ¥1,212.00 | +0.00% | 29.9B | 0.00 | ¥413,067,936.00 | N/A |
| 9158.T | ¥794.00 | -1.49% | 22.7B | 7.96 | ¥97.35 | N/A |
| 194A.T | ¥1,442.00 | -6.49% | 11B | 25.38 | ¥57.44 | N/A |
| 7133.T | ¥1,190.00 | -2.38% | 8.6B | 17.04 | ¥70.38 | +1.67% |
| 8769.T | ¥516.00 | +0.39% | 8.2B | 11.96 | ¥43.73 | +3.25% |
Stock Comparison
Elan Corporation (JPX: 6099.T)
6197.T vs 6099.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 6099.T has a market cap of 46.7B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 6099.T trades at ¥786.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 6099.T's P/E ratio is 16.00. In terms of profitability, 6197.T's ROE is +0.16%, compared to 6099.T's ROE of +0.21%. Regarding short-term risk, 6197.T is less volatile compared to 6099.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 6099.T's competition here
Charm Care Corporation (JPX: 6062.T)
6197.T vs 6062.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 6062.T has a market cap of 44.2B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 6062.T trades at ¥1,373.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 6062.T's P/E ratio is 11.90. In terms of profitability, 6197.T's ROE is +0.16%, compared to 6062.T's ROE of +0.17%. Regarding short-term risk, 6197.T is less volatile compared to 6062.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 6062.T's competition here
Amvis Holdings, Inc. (JPX: 7071.T)
6197.T vs 7071.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 7071.T has a market cap of 35.3B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 7071.T trades at ¥373.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 7071.T's P/E ratio is 12.26. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7071.T's ROE of +0.08%. Regarding short-term risk, 6197.T is less volatile compared to 7071.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7071.T's competition here
I'rom Group Co., Ltd. (JPX: 2372.T)
6197.T vs 2372.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 2372.T has a market cap of 33.8B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 2372.T trades at ¥2,790.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 2372.T's P/E ratio is 131.60. In terms of profitability, 6197.T's ROE is +0.16%, compared to 2372.T's ROE of +0.11%. Regarding short-term risk, 6197.T is less volatile compared to 2372.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 2372.T's competition here
Saint-Care Holding Corporation (JPX: 2374.T)
6197.T vs 2374.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 2374.T has a market cap of 29.9B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 2374.T trades at ¥1,212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 2374.T's P/E ratio is 0.00. In terms of profitability, 6197.T's ROE is +0.16%, compared to 2374.T's ROE of +0.10%. Regarding short-term risk, 6197.T is less volatile compared to 2374.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 2374.T's competition here
CUC Inc. (JPX: 9158.T)
6197.T vs 9158.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 9158.T has a market cap of 22.7B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 9158.T trades at ¥794.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 9158.T's P/E ratio is 7.96. In terms of profitability, 6197.T's ROE is +0.16%, compared to 9158.T's ROE of +0.09%. Regarding short-term risk, 6197.T is less volatile compared to 9158.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 9158.T's competition here
WOLVES HAND Co., Ltd. (JPX: 194A.T)
6197.T vs 194A.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 194A.T has a market cap of 11B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 194A.T trades at ¥1,442.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 194A.T's P/E ratio is 25.38. In terms of profitability, 6197.T's ROE is +0.16%, compared to 194A.T's ROE of +0.30%. Regarding short-term risk, 6197.T is less volatile compared to 194A.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 194A.T's competition here
HYUGA PRIMARY CARE Co.,Ltd. (JPX: 7133.T)
6197.T vs 7133.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 7133.T has a market cap of 8.6B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 7133.T trades at ¥1,190.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 7133.T's P/E ratio is 17.04. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7133.T's ROE of +0.20%. Regarding short-term risk, 6197.T is less volatile compared to 7133.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7133.T's competition here
Advantage Risk Management Co., Ltd. (JPX: 8769.T)
6197.T vs 8769.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 8769.T has a market cap of 8.2B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 8769.T trades at ¥516.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 8769.T's P/E ratio is 11.96. In terms of profitability, 6197.T's ROE is +0.16%, compared to 8769.T's ROE of +0.17%. Regarding short-term risk, 6197.T is less volatile compared to 8769.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 8769.T's competition here
AS Partners Co. Ltd. (JPX: 160A.T)
6197.T vs 160A.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 160A.T has a market cap of 7.4B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 160A.T trades at ¥2,088.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 160A.T's P/E ratio is 6.25. In terms of profitability, 6197.T's ROE is +0.16%, compared to 160A.T's ROE of +0.23%. Regarding short-term risk, 6197.T is less volatile compared to 160A.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 160A.T's competition here
UCHIYAMA HOLDINGS Co.,Ltd. (JPX: 6059.T)
6197.T vs 6059.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 6059.T has a market cap of 6.7B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 6059.T trades at ¥348.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 6059.T's P/E ratio is 22.61. In terms of profitability, 6197.T's ROE is +0.16%, compared to 6059.T's ROE of +0.02%. Regarding short-term risk, 6197.T is less volatile compared to 6059.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 6059.T's competition here
Care Twentyone Corporation (JPX: 2373.T)
6197.T vs 2373.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 2373.T has a market cap of 5.5B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 2373.T trades at ¥404.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 2373.T's P/E ratio is 51.60. In terms of profitability, 6197.T's ROE is +0.16%, compared to 2373.T's ROE of +0.02%. Regarding short-term risk, 6197.T is less volatile compared to 2373.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 2373.T's competition here
Living Platform,Ltd. (JPX: 7091.T)
6197.T vs 7091.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 7091.T has a market cap of 5.3B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 7091.T trades at ¥1,205.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 7091.T's P/E ratio is 13.39. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7091.T's ROE of +0.17%. Regarding short-term risk, 6197.T is less volatile compared to 7091.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7091.T's competition here
Hi-CRATES CO.,LTD. (JPX: 4172.T)
6197.T vs 4172.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 4172.T has a market cap of 4.8B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 4172.T trades at ¥2,214.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 4172.T's P/E ratio is 10.72. In terms of profitability, 6197.T's ROE is +0.16%, compared to 4172.T's ROE of +0.11%. Regarding short-term risk, 6197.T is less volatile compared to 4172.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 4172.T's competition here
Japan Hospice Holdings Inc. (JPX: 7061.T)
6197.T vs 7061.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 7061.T has a market cap of 4.7B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 7061.T trades at ¥568.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 7061.T's P/E ratio is 15.69. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7061.T's ROE of +0.08%. Regarding short-term risk, 6197.T is less volatile compared to 7061.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7061.T's competition here
AIAI Group Corporation (JPX: 6557.T)
6197.T vs 6557.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 6557.T has a market cap of 4.4B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 6557.T trades at ¥700.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 6557.T's P/E ratio is 7.17. In terms of profitability, 6197.T's ROE is +0.16%, compared to 6557.T's ROE of +0.20%. Regarding short-term risk, 6197.T is less volatile compared to 6557.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 6557.T's competition here
Sunwels Co.,Ltd. (JPX: 9229.T)
6197.T vs 9229.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 9229.T has a market cap of 4.3B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 9229.T trades at ¥130.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 9229.T's P/E ratio is -2.58. In terms of profitability, 6197.T's ROE is +0.16%, compared to 9229.T's ROE of -0.23%. Regarding short-term risk, 6197.T is less volatile compared to 9229.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 9229.T's competition here
teno. Holdings Company Limited (JPX: 7037.T)
6197.T vs 7037.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 7037.T has a market cap of 3.9B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 7037.T trades at ¥864.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 7037.T's P/E ratio is 23.29. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7037.T's ROE of +0.09%. Regarding short-term risk, 6197.T is less volatile compared to 7037.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7037.T's competition here
Miahelsa Holdings Corporation (JPX: 7129.T)
6197.T vs 7129.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 7129.T has a market cap of 3.2B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 7129.T trades at ¥1,155.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 7129.T's P/E ratio is 63.07. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7129.T's ROE of +0.05%. Regarding short-term risk, 6197.T is less volatile compared to 7129.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7129.T's competition here
FB Care Service Co.,Ltd. (JPX: 9220.T)
6197.T vs 9220.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 9220.T has a market cap of 3B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 9220.T trades at ¥1,220.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 9220.T's P/E ratio is 6.74. In terms of profitability, 6197.T's ROE is +0.16%, compared to 9220.T's ROE of +0.12%. Regarding short-term risk, 6197.T is less volatile compared to 9220.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 9220.T's competition here
Care Service Co.,Ltd. (JPX: 2425.T)
6197.T vs 2425.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 2425.T has a market cap of 2.5B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 2425.T trades at ¥666.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 2425.T's P/E ratio is 22.11. In terms of profitability, 6197.T's ROE is +0.16%, compared to 2425.T's ROE of +0.04%. Regarding short-term risk, 6197.T is less volatile compared to 2425.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 2425.T's competition here
CEDAR.Co.,Ltd. (JPX: 2435.T)
6197.T vs 2435.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 2435.T has a market cap of 2.3B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 2435.T trades at ¥210.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 2435.T's P/E ratio is 4.46. In terms of profitability, 6197.T's ROE is +0.16%, compared to 2435.T's ROE of +0.31%. Regarding short-term risk, 6197.T is less volatile compared to 2435.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 2435.T's competition here
D&m Co. Co. Ltd. (JPX: 189A.T)
6197.T vs 189A.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 189A.T has a market cap of 2.3B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 189A.T trades at ¥1,014.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 189A.T's P/E ratio is 10.32. In terms of profitability, 6197.T's ROE is +0.16%, compared to 189A.T's ROE of +0.10%. Regarding short-term risk, 6197.T is less volatile compared to 189A.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 189A.T's competition here
AHC Group Inc. (JPX: 7083.T)
6197.T vs 7083.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 7083.T has a market cap of 2.2B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 7083.T trades at ¥1,075.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 7083.T's P/E ratio is 265.35. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7083.T's ROE of +0.01%. Regarding short-term risk, 6197.T is less volatile compared to 7083.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7083.T's competition here
Artra Group Corporation (JPX: 6029.T)
6197.T vs 6029.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 6029.T has a market cap of 2B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 6029.T trades at ¥202.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 6029.T's P/E ratio is 12.44. In terms of profitability, 6197.T's ROE is +0.16%, compared to 6029.T's ROE of +0.10%. Regarding short-term risk, 6197.T is less volatile compared to 6029.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 6029.T's competition here
Fureasu Co.,Ltd. (JPX: 7062.T)
6197.T vs 7062.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 7062.T has a market cap of 2B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 7062.T trades at ¥785.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 7062.T's P/E ratio is 3.98. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7062.T's ROE of +0.26%. Regarding short-term risk, 6197.T is less volatile compared to 7062.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7062.T's competition here
Recovery International Co.,Ltd. (JPX: 9214.T)
6197.T vs 9214.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 9214.T has a market cap of 1.7B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 9214.T trades at ¥1,290.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 9214.T's P/E ratio is 21.25. In terms of profitability, 6197.T's ROE is +0.16%, compared to 9214.T's ROE of +0.11%. Regarding short-term risk, 6197.T is less volatile compared to 9214.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 9214.T's competition here
Terminalcare Support Institute Inc. (JPX: 7362.T)
6197.T vs 7362.T Comparison July 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 100.6B. In comparison, 7362.T has a market cap of 1.3B. Regarding current trading prices, 6197.T is priced at ¥1,111.00 on the JPX, while 7362.T trades at ¥887.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.22, whereas 7362.T's P/E ratio is 11.44. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7362.T's ROE of +0.09%. Regarding short-term risk, 6197.T is less volatile compared to 7362.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7362.T's competition here